Tyra Biosciences, Inc.

NASDAQ:TYRA

12.37 (USD) • At close August 28, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 98.49100.72191.966103.89299.49254.36658.006215.652232.413241.701251.213263.211275.107292.499302.182312.823135.204140.63815.224
Short Term Investments 197.781218.222249.475256.238274.306128.096145.463000000000000
Cash and Short Term Investments 296.271318.943341.441360.13373.796382.462203.469215.652232.413241.701251.213263.211275.107292.499302.182312.823135.204140.63815.224
Net Receivables 1.71.821.901.50000000000000
Inventory 0000000000000000000
Other Current Assets 4.1843.8234.0223.5817.6568.31615.7048.9788.3335.0086.0758.524.3843.0523.751.3560.2170.190.057
Total Current Assets 302.155324.566347.463365.611378.574390.778211.671224.63240.746246.709257.288267.471277.299294.025304.057313.501135.421140.82815.281
Non-Current Assets:
Property, Plant & Equipment, Net 7.2357.4687.7197.9758.1948.0058.1547.3837.43.4723.5433.6423.7373.5842.0891.9081.9230.4670.466
Goodwill 0000000000000000000
Intangible Assets 0000000000000000000
Goodwill and Intangible Assets 00000000000000-0.5050000
Long Term Investments 000111111011110.2430.24300.2430
Tax Assets 000000000000000.2620000
Other Non-Current Assets 12.10911.4428.3766.0064.6934.9585.0325.3450.8664.8744.353.8725.0820.3620.050.3182.5740.2710.264
Total Non-Current Assets 19.34418.9116.09514.98113.88713.96314.18613.7289.2668.3468.8938.5149.8194.9462.6442.4694.4970.9810.73
Total Assets 321.499343.476363.558380.592392.461404.741225.857238.358250.012255.055266.181275.985287.118298.971306.701315.97139.918141.80916.011
Liabilities & Equity:
Current Liabilities:
Account Payables 2.2452.50.591.1651.5772.8794.6622.3081.441.281.1452.7472.3431.3560.5992.0681.8750.8410.664
Short Term Debt 0.4410.4260.4120.3980.7660.370.560.2960.2880.1440.280.2540.2460.2380.4040.270.1360.0880.142
Tax Payables 0000000000000000000
Deferred Revenue 0000-0.38300000000000000
Other Current Liabilities 11.08411.3213.59210.818.0395.46710.1117.5433.6772.2584.2762.4882.8663.3072.6132.431.7380.6061.052
Total Current Liabilities 13.7714.24614.59412.37310.3828.71615.33310.1475.4053.6825.7015.4895.4554.9013.6164.7683.7491.5351.858
Non-Current Liabilities:
Long Term Debt 5.5825.6965.815.926.0166.1176.2165.9645.9272.4442.4822.5142.5492.5830.9811.0371.09100
Deferred Revenue Non-Current 00000000000000-0.2620000
Deferred Tax Liabilities Non-Current 000000000000000.2620000
Other Non-Current Liabilities 000.0030.0110.020.0290.0460.0770.1080.1390.1690.2260.2610.3030.3670.434157.745157.79627.791
Total Non-Current Liabilities 5.5825.6965.8135.9316.0366.1466.2626.0416.0352.5832.6512.742.812.8861.3481.471158.836157.79627.791
Total Liabilities 19.35219.94220.40718.30416.41814.86221.59516.18811.446.2658.3528.2298.2657.7874.9646.239162.585159.33129.649
Equity:
Preferred Stock 000000000000000315.97157.274157.27427.651
Common Stock 0.0050.0050.0050.0050.0050.0050.0040.0040.0040.0040.0040.0040.0040.0040.0040.004000
Retained Earnings -307.556-279.458-251.311-225.74-201.724-183.022-164.83-142-120.848-107.576-95.696-82.801-70.292-55.197-40.371-30.441-23.798-18.286-14.077
Accumulated Other Comprehensive Income/Loss 0.4360.6880.771.752-0.184-0.0060.381000-0-0-000-315.97-000
Other Total Stockholders Equity 609.262602.299593.687586.271577.946572.902368.707364.166359.416356.362353.521350.553349.141346.377342.104656.138-156.143-156.51-27.212
Total Shareholders Equity 302.147323.534343.151362.288376.043389.879204.262222.17238.572248.79-95.696267.756278.853291.184301.737309.731-22.667-17.522-13.638
Total Equity 302.147323.534343.151362.288376.043389.879204.262222.17238.572248.79-95.696267.756278.853291.184301.737309.731-22.667-17.522-13.638
Total Liabilities & Shareholders Equity 321.499343.476363.558380.592392.461404.741225.857238.358250.012255.055-87.344275.985287.118298.971306.701315.97139.918141.80916.011